- ►stanford.edu [PDF] LF Van Gaal, AM Rissanen, AJ Scheen, O Ziegler, S … - The Lancet, 2005 - Elsevier Weight loss at 1 year was significantly greater in patients treated with rimonabant 5 mg (mean
−3·4 kg [SD 5·7]; p=0·002 vs placebo) and 20 mg (−6·6 kg [7·2]; p<0·001 vs placebo)
compared with placebo (−1·8 kg ... Cited by 688 - Related articles - All 24 versions
AM McNeill, WD Rosamond, CJ Girman, SH … - Diabetes care, 2005 - Am Diabetes Assoc RESULTS— The metabolic syndrome was present in ∼23% of individuals without diabetes or prevalent
CVD at baseline. Over an average of 11 years of follow-up, 879 incident CHD and 216 ischemic stroke
events occurred. Among the ... Cited by 456 - Related articles - All 13 versions
- ►biosino.org [PDF] JP Després, I Lemieux - NATURE-LONDON-, 2006 - Springer Despite the fact that the obesity epidemic has received intense media cover- age, many physicians
still fail to recognize that the rapidly growing prevalence of type 2 diabetes in their practice is
the result of our “toxic” ... Cited by 433 - Related articles - BL Direct - All 9 versions
DB Carr, KM Utzschneider, RL Hull, K Kodama, BM … - Diabetes, 2004 - Am Diabetes Assoc The underlying pathophysiology of the metabolic syndrome is the subject of debate, with both insulin
resistance and obesity considered as important factors. We evaluated the differential effects of
insulin resistance and central body ... Cited by 348 - Related articles - BL Direct - All 5 versions
- ►ahajournals.org [PDF] KJ Hunt, RG Resendez, K Williams, SM Haffner, MP … - Circulation, 2004 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone: 410-528-4050. Permissions:
Permissions & Rights Desk, Lippincott Williams & Wilkins, a division of Wolters ... Health
Organization Metabolic Syndrome in ... Cited by 330 - Related articles - BL Direct - All 10 versions
AJ Scheen, N Finer, P Hollander, MD Jensen, LF Van … - The Lancet, 2006 - Elsevier 1047 overweight or obese type 2 diabetes patients (body-mass index 27–40 kg/m 2 ) with a
haemoglobin A 1c (HbA 1c ) concentration of 6·5–10·0% (mean 7·3% [SD 0·9] at baseline) already
on metformin or sulphonylurea ... Cited by 287 - Related articles - All 12 versions
- ►ahajournals.org S Haffner, H Taegtmeyer - Circulation, 2003 - Am Heart Assoc Clustering of cardiovascular risk factors, specifically, hypertension, diabetes, dyslipidemia and
obesity, was described in the 1960s and 1970s. 1,2 However, these studies did not emphasize possible
etiologies for this clustering ... Cited by 274 - Related articles - BL Direct - All 7 versions
CJ Girman, T Rhodes, M Mercuri, K Pyörälä, J … - The American journal of …, 2004 - Elsevier The metabolic syndrome, which is a set of lipid and nonlipid risk factors of metabolic origin linked
with insulin resistance, is believed to be associated with an elevated risk for cardiovascular
disease, but few have studied this ... Cited by 250 - Related articles - All 4 versions
TJ Orchard, M Temprosa, R Goldberg, S … - Annals of internal …, 2005 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg Add to Facebook Add
to Reddit Add to Technorati Add to Twitter What's this? ... Background: The metabolic syndrome is a
high-risk state for diabetes and ... Cited by 242 - Related articles - All 7 versions
DE Moller, KD Kaufman - 2004 - Annual Reviews The metabolic syndrome is a cluster of interrelated common clinical disorders, including obesity,
insulin resistance, glucose intolerance, hypertension, and dyslipidemia (hypertriglyceridemia and
low HDL cholesterol levels). ... Cited by 231 - Related articles - All 6 versions
